BIOMAT Database Logo BIOMAT Database Logo

Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. I. Alkyl 4-(2-oxo-1,2,3,4-tetrahydro-6-quinolyloxy)butyrates and related compounds. 1983

T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011804 Quinolines
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. III. N-cyclohexyl-N-(2-hydroxyethyl)-4-(1,2-dihydro-2-oxo-6-quinolyloxy)-butyramide and related compounds.
March 1983, Chemical & pharmaceutical bulletin,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. II. 6-[3-(1-cyclohexyl-5-tetrazolyl)propoxy]-1,2-dihydro-2-oxoquinoline and related compounds.
April 1983, Chemical & pharmaceutical bulletin,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors, IV. Synthesis and biological activity of the metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy]-2-oxo-1,2,3,4- tetrahydroquinoline (OPC-13013).
March 1985, Chemical & pharmaceutical bulletin,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
[Synthesis of 1-dialkylamino-alkyl-2-aryl-4-oxo-1,2,3,4-tetrahydro-quinazolines].
June 1965, Arzneimittel-Forschung,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Synthesis of 1,2,3,4-tetrahydro-beta-carboline derivatives as hepatoprotective agents. II. Alkyl 1,2,3,4-tetrahydro-beta-carboline-2-carbodithioates.
August 1987, Chemical & pharmaceutical bulletin,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Platelet aggregation inhibitors. 6. 2-Thioadenosine derivatives.
December 1973, Journal of medicinal chemistry,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARgamma activators.
August 2007, Bioorganic & medicinal chemistry letters,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors.
January 2018, European journal of medicinal chemistry,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
Antimycotic action of alkyl derivatives of 5-(benzenesulfonamide)-1,2,3,4-tetrahydro-2-thioxo-4-pyrimidinon e.
August 1987, Il Farmaco; edizione scientifica,
T Nishi, and K Yamamoto, and T Shimizu, and T Kanbe, and Y Kimura, and K Nakagawa
4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
May 1989, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!